Report post

Who is Mesoblast limited?

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases.

Why is Mesoblast a global leader in cellular medicine?

The therapeutic and commercial properties offered by the MLC platform technology have attributed significantly to Mesoblast’s position as a global leader in cellular medicines.

Can Mesoblast Therapy treat graft-versus-host disease (GVHD)?

The U.S. Food and Drug Administration on Wednesday approved Mesoblast's cell therapy for treating a type of complication that occurs after a stem cell or bone marrow transplant called graft-versus-host disease (GVHD).

The World's Leading Crypto Trading Platform

Get my welcome gifts